Medion Farma Jaya has expanded its international market reach with the export of pharmaceutical products to new target countries. In December 2025, the company conducted its first export shipment to Taiwan, Zambia, and Egypt. This expansion is part of Medion’s growth strategy, following its successful entry into more than 20 countries across Asia and Africa, while strengthening the competitiveness of national pharmaceutical products in the global market.
To ensure a smooth rollout, Medion carefully selected potential distributors through its export partner, Artha Vena International (AVI), offering high-quality export-ready products at competitive prices. The company provided comprehensive scientific data and technical support to distributors, ensuring effective marketing and timely fulfillment of orders. Additionally, Medion customized product labels to comply with local languages and regulations, ensuring products are easily accepted and used in each market.
Products exported to Zambia included the antibiotics Amoxitin NF and Therapy, as well as the vitamins Aminovit, Broiler Vita, and Vita Chicks Golden. Vita Stress and Reduvir were shipped to Taiwan, while Imustim was delivered to Egypt.
All products were manufactured according to Good Manufacturing Practice (GMP) standards and shipped via sea and air using strict distribution protocols, ensuring that product quality was maintained until arrival. Medion aims to continuously expand its export portfolio, particularly herbal products that help minimize the risk of Antimicrobial Resistance (AMR) and reach additional countries, and reinforce its position as a leading animal health pharmaceutical manufacturer in Asia and Africa.